According to Cryo-Cell's latest financial reports the company's current earnings (TTM) are -$12.76 M. a decrease over its 2022 earnings that were of $4.84 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | -$12.13 M | -350.54% |
2022 | $4.84 M | 21.32% |
2021 | $3.99 M | -39.39% |
2020 | $6.58 M | 29.22% |
2019 | $5.09 M | -1.35% |
2018 | $5.16 M | 4.84% |
2017 | $4.92 M | -421.38% |
2016 | -$1.54 M | -168.03% |
2015 | $2.25 M | 23.23% |
2014 | $1.82 M | 14.46% |
2013 | $1.59 M | -147.02% |
2012 | -$3.4 M | 1504.65% |
2011 | -$0.22 M | -106.68% |
2010 | $3.17 M | 3.71% |
2009 | $3.05 M | |
2007 | -$4.68 M | |
2005 | $1.22 M | |
2003 | -$7.23 M | 35.46% |
2002 | -$5.34 M | 998.27% |
2001 | -$0.49 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Omnicell
OMCL | -$34.87 M | 173.31% | ๐บ๐ธ USA |
Global Cord Blood CORBF | $94.91 M | -844.01% | ๐ญ๐ฐ Hong Kong |
CorVel Corporation
CRVL | $95.09 M | -845.42% | ๐บ๐ธ USA |